| Note |
These minors are victims. Jean - myoclonic seizures. Michael - akinetic seizures. Carol - Lennox-Gastaut syndrome. These children, victims of minor motor seizures, may benefit from the many advantages offered by 'Rivotril.' Effective in reducing the frequency and/or severity of a variety of epileptic seizures: akinetic seizures, myoclonic seizures, Lennox-Gastuat syndrome (petit mal variant), absence seizures (where succinimide therapy has failed). Flexible dosage regimen encourages patient compliance. No reports of incompatibility with a ketogenic diet. Economical, for long-term therapy. May be used concomitantly with most other anticonvulsants. 'Rivotril' has not been associated with the severe side effects seen with some other anticonvulsant medications. No reports of serious side effects, such as hepatotoxicity. Very low incidence of nausea and G.I. upsets. No serious problems of drug interaction (eg. ASA). Proven safety record in long-term administration. Drowsiness, which may occur, is generally dose-related and may be well controlled with proper dosage adjustment. Rivotril for the victims of minor motor seizures. |
